Results
|
|
11241.
|
|
|
|
11242.
|
|
|
|
11243.
|
Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. [electronic resource] by
- Klein, Martina
- Schermuly, Ralph T
- Ellinghaus, Peter
- Milting, Hendrik
- Riedl, Bernd
- Nikolova, Sevdalina
- Pullamsetti, Soni S
- Weissmann, Norbert
- Dony, Eva
- Savai, Rajkumar
- Ghofrani, Hossein A
- Grimminger, Friedrich
- Busch, Andreas E
- Schäfer, Stefan
Producer: 20081202
In:
Circulation vol. 118
Availability: No items available.
|
|
|
11244.
|
Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777. [electronic resource] by
- Beauparlant, Pierre
- Bédard, Dominique
- Bernier, Cynthia
- Chan, Helen
- Gilbert, Karine
- Goulet, Daniel
- Gratton, Michel-Olivier
- Lavoie, Manon
- Roulston, Anne
- Turcotte, Emilie
- Watson, Mark
Producer: 20090715
In:
Anti-cancer drugs vol. 20
Availability: No items available.
|
|
|
11245.
|
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. [electronic resource] by
- Golshayan, Ali Reza
- George, Saby
- Heng, Daniel Y
- Elson, Paul
- Wood, Laura S
- Mekhail, Tarek M
- Garcia, Jorge A
- Aydin, Hakan
- Zhou, Ming
- Bukowski, Ronald M
- Rini, Brian I
Producer: 20090116
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27
Availability: No items available.
|
|
|
11246.
|
A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer. [electronic resource] by
- Lind, Joline S W
- Dingemans, Anne-Marie C
- Groen, Harry J M
- Thunnissen, Frederik B
- Bekers, Otto
- Heideman, Daniëlle A M
- Honeywell, Richard J
- Giovannetti, Elisa
- Peters, Godefridus J
- Postmus, Pieter E
- van Suylen, Robert Jan
- Smit, Egbert F
Producer: 20100812
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16
Availability: No items available.
|
|
|
11247.
|
|
|
|
11248.
|
|
|
|
11249.
|
|
|
|
11250.
|
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. [electronic resource] by
- Chang, Yong S
- Adnane, Jalila
- Trail, Pamela A
- Levy, Joan
- Henderson, Arris
- Xue, Dahai
- Bortolon, Elizabeth
- Ichetovkin, Marina
- Chen, Charles
- McNabola, Angela
- Wilkie, Dean
- Carter, Christopher A
- Taylor, Ian C A
- Lynch, Mark
- Wilhelm, Scott
Producer: 20070522
In:
Cancer chemotherapy and pharmacology vol. 59
Availability: No items available.
|
|
|
11251.
|
|
|
|
11252.
|
NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. [electronic resource] by
- Greten, Florian R
- Arkan, Melek C
- Bollrath, Julia
- Hsu, Li-Chung
- Goode, Jason
- Miething, Cornelius
- Göktuna, Serkan I
- Neuenhahn, Michael
- Fierer, Joshua
- Paxian, Stephan
- Van Rooijen, Nico
- Xu, Yajun
- O'Cain, Timothy
- Jaffee, Bruce B
- Busch, Dirk H
- Duyster, Justus
- Schmid, Roland M
- Eckmann, Lars
- Karin, Michael
Producer: 20071019
In:
Cell vol. 130
Availability: No items available.
|
|
|
11253.
|
|
|
|
11254.
|
|
|
|
11255.
|
|
|
|
11256.
|
Blockade of ataxia telangiectasia mutated sensitizes hepatoma cell lines to sorafenib by interfering with Akt signaling. [electronic resource] by
- Fujimaki, Shun
- Matsuda, Yasunobu
- Wakai, Toshifumi
- Sanpei, Ayumi
- Kubota, Masayuki
- Takamura, Masaaki
- Yamagiwa, Satoshi
- Yano, Masahiko
- Ohkoshi, Shogo
- Aoyagi, Yutaka
Producer: 20120427
In:
Cancer letters vol. 319
Availability: No items available.
|
|
|
11257.
|
Sorafenib targets BCR kinases and blocks migratory and microenvironmental survival signals in CLL cells. [electronic resource] by
- López-Guerra, M
- Xargay-Torrent, S
- Pérez-Galán, P
- Saborit-Villarroya, I
- Rosich, L
- Villamor, N
- Aymerich, M
- Roué, G
- Campo, E
- Montserrat, E
- Colomer, D
Producer: 20120807
In:
Leukemia vol. 26
Availability: No items available.
|
|
|
11258.
|
|
|
|
11259.
|
Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma. [electronic resource] by
- Miyahara, Koji
- Nouso, Kazuhiro
- Tomoda, Takeshi
- Kobayashi, Sayo
- Hagihara, Hiroaki
- Kuwaki, Kenji
- Toshimori, Junichi
- Onishi, Hideki
- Ikeda, Fusao
- Miyake, Yasuhiro
- Nakamura, Shinichiro
- Shiraha, Hidenori
- Takaki, Akinobu
- Yamamoto, Kazuhide
Producer: 20120213
In:
Journal of gastroenterology and hepatology vol. 26
Availability: No items available.
|
|
|
11260.
|
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. [electronic resource] by
- Caraglia, M
- Giuberti, G
- Marra, M
- Addeo, R
- Montella, L
- Murolo, M
- Sperlongano, P
- Vincenzi, B
- Naviglio, S
- Prete, S Del
- Abbruzzese, A
- Stiuso, P
Producer: 20111101
In:
Cell death & disease vol. 2
Availability: No items available.
|